A new surgical device developed at the University of Michigan could make it quicker and easier to connect arteries in complicated procedures such as reconstructing a breast after a mastectomy, or a severely injured leg after a car accident.
Rolling out what it's calling a "street view for cyberspace," Censys — a tech startup based on technology developed at the University of Michigan — has launched a commercially available version of its internetwide scanning tool.
One of the selling points of autonomous vehicles is the chance for drivers to be more productive while traveling. But some, suffering from motion sickness, won't be able to take advantage of relinquishing the wheel.
While the Big Three automakers are still in the research and development phase, University of Michigan startup May Mobility already has tested its bright green-and-white driverless shuttles on public streets in downtown Detroit, and has ambitious plans for growth.
Kelly Sexton, an assistant vice chancellor at North Carolina State University, has been named associate vice president for research — technology transfer and innovation partnerships at the University of Michigan.
The total volume of research at the University of Michigan reached a record high of $1.48 billion in the fiscal year that ended June 30, a 6.4 percent increase from the previous year.
University of Michigan researchers reported 444 new inventions in fiscal year 2017 — up from last year's 428 — and the fifth straight year of more than 400 inventions from U-M faculty.
Seven technologies demonstrating high potential to help solve transportation issues are receiving $600,000 from the University of Michigan's Michigan Translational Research and Commercialization Statewide Innovation Hub program to continue their advancement into the commercial market.
A University of Michigan startup that's developing a non-invasive way to remove diseased tissue from cancer patients using high-intensity ultrasound has attracted $8.3 million in Series B financing.
Neurable, a University of Michigan startup that developed brain-computer interface technology based on breakthrough neuroscience, has raised $2 million in seed funding to bring its software platform to market.
Mike Psarouthakis has been named director of the University of Michigan's Tech Transfer Venture Center.
The Venture Center is responsible for helping to identify, develop and launch new startups based on U-M technologies, and works alongside licensing, legal and marketing specialists within U-M Tech Transfer.
In an effort to make safer, longer-lasting lithium-ion batteries for technologies like electric vehicles, smartphones and laptops, a University of Michigan startup has formed a $1.5 million joint venture with two major players in the industry.
The University of Michigan signed a record 173 license and option agreements with companies seeking to commercialize the discoveries of university researchers in the past fiscal year.
Fusion Coolant Systems, a University of Michigan spinout based in Canton, announced Tuesday it had raised $1.25 million in its first close of Series B funding.
Kura Oncology Inc., a clinical stage biopharmaceutical company that develops therapies for cancer patients, is now trading on the NASDAQ after an initial public offering.
The University of Michigan will award more than $1 million in grant funding to technologies that demonstrate high potential for solving transportation's toughest challenges.
+ more information
Sakti3, a University of Michigan startup that pioneered a new battery platform, has been purchased by Dyson in a $90 million deal that follows an initial investment of $15 million earlier this year.
The University of Michigan spurred a record 19 startups last year, up from 14 a year ago, reflecting the substantial activity connected to its faculty's rich array of research discoveries.
U-M Tech Transfer set several records for annual performance in fiscal year 2015 including patents, agreements, startups and revenue.
Electric Field Solutions, a U-M startup that uses technology first developed for measuring electric fields caused by dust storms on the surface of Mars, has been acquired by Premier, a gas and electrical industries service company.
The University of Michigan signed an agreement with PDL BioPharma Inc. to sell a portion of its royalty interest in Cerdelga (eliglustat) capsules, a first-line oral treatment for adults with Gaucher disease type 1.